JiangXi Tianxin Pharmaceutical Co (SHSE:603235) COGS-to-Revenue : 0.60 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is JiangXi Tianxin Pharmaceutical Co COGS-to-Revenue?

JiangXi Tianxin Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥296 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥494 Mil.

JiangXi Tianxin Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.60.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. JiangXi Tianxin Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 was 40.07%.

JiangXi Tianxin Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for JiangXi Tianxin Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JiangXi Tianxin Pharmaceutical Co COGS-to-Revenue Chart

JiangXi Tianxin Pharmaceutical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.49

0.46

0.57

0.63

0.62

JiangXi Tianxin Pharmaceutical Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial											0.68	0.57	0.64	0.56	0.60

JiangXi Tianxin Pharmaceutical Co COGS-to-Revenue Calculation

JiangXi Tianxin Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1161.709	/	1881.993
	=	0.62

JiangXi Tianxin Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	296.335	/	494.498
	=	0.60

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

JiangXi Tianxin Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	296.335 / 494.498
	=	40.07 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

JiangXi Tianxin Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of JiangXi Tianxin Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Le'anjiang Industrial Park, Jiangxi Province, Leping, CHN, 333300

Website

http://www.txpharm.com

JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Headlines

No Headlines